Yoshiki Itoh

New Chiral Ruthenium Bis(oxazolinyl)pyridine Catalyst. Efficient Asymmetric Cyclopropanation of Olefins with Diazoacetates

Hisao Nishiyama, Yoshiki Itoh, Hideki Matsumoto et al. · Journal of the American Chemical Society · 1994 · 407 citations

Natural Sciences, Chemistry, Catalysis +10

High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR–SSOP–Luminex method in the Japanese population

Yoshiki Itoh, Nobuhisa Mizuki, Tsuyako Shimada et al. · Immunogenetics · 2005 · 289 citations

Life Sciences, Genetics, Molecular Genetics +15

Chiral Ruthenium(II)–Bis(2-oxazolin-2-yl)pyridine Complexes. Asymmetric Catalytic Cyclopropanation of Olefins and Diazoacetates

Hisao Nishiyama, Yoshiki Itoh, Yuji Sugawara et al. · Bulletin of the Chemical Society of Japan · 1995 · 250 citations

Natural Sciences, Chemistry, Catalysis +16

Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist:  1-[(3<i>R</i>,4<i>R</i>)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2<i>H</i>-benzimidazol-2-one (J-113397)

Hiroshi Kawamoto, Satoshi Ozaki, Yoshiki Itoh et al. · Journal of Medicinal Chemistry · 1999 · 204 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist

Satoshi Ozaki, Hiroshi Kawamoto, Yoshiki Itoh et al. · European Journal of Pharmacology · 2000 · 167 citations

Medicine, Medicinal Chemistry, Pharmacology +7